• Exchange: Stuttgart
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

FAD1:GR

3.971 EUR 0.172 4.53%

As of 02:03:51 ET on 12/19/2014.

Snapshot for Advaxis Inc (FAD1)

Open: 3.894 Day's Range: 3.894 - 3.971 Volume: 0
Previous Close: 3.799 52wk Range: 1.746 - 4.558 1-Yr Rtn: +32.68%

Stock Chart for FAD1

No chart data available.
  • FAD1:GR 3.971
  • 1D
  • 1M
  • 1Y
3.799
Interactive FAD1 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for FAD1

Current P/E Ratio (ttm) -
Estimated P/E(10/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (10/2014) -1.1300
Est. PEG Ratio -
Market Cap (M EUR) 77.51
Shares Outstanding (M) 19.52
30 Day Average Volume 182
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/20/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for FAD1

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for FAD1

Advaxis Inc., is a biotechnology company. The Company develops therapeutic cancer vaccines targeting cervical, head & neck, breast, prostate, and other cancers.

Daniel J O'ConnorPresident/CEOGregory T Mayes "Greg"Exec VP/COO
Robert PetitExec VP/Chief Scientific OfcrSara BonsteinSenior VP/CFO
More Company Profile & Key Executives for FAD1

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil